Prognostic Value and Potential Regulatory Mechanism of H19 in Stomach Adenocarcinoma.
Hongyuan GuoXu GuoYuanyuan SuMinghui LiuXi ChenHao ZhuZheng FuPublished in: Journal of oncology (2022)
The first lncRNA discovered, H19, has been found to participate in the regulation of diverse biological processes, including the pathogenesis of stomach adenocarcinoma. In addition to its oncogenic function in tumor formation, a high level of H19 in tumor tissues has also been reported to be an indicator for poor prognosis. However, although many previous works have investigated the level of H19 as an independent indicator for prognosis, the real value of H19 in predicting survival has rarely been evaluated. In this study, we established a prognostic model and nomogram for stomach adenocarcinoma by combining the expression level of H19 with traditional indices, which showed the value of H19 in predicting the survival rates of patients. In addition, we investigated the mechanism underlying the correlation of the H19 level in cancer tissue with poor prognosis in patients. Our results showed that H19 could function as ceRNA by sponging five miRNAs, which may promote the progression of cancer.
Keyphrases
- poor prognosis
- long non coding rna
- end stage renal disease
- ejection fraction
- squamous cell carcinoma
- newly diagnosed
- prognostic factors
- chronic kidney disease
- papillary thyroid
- peritoneal dialysis
- gene expression
- transcription factor
- young adults
- patient reported outcomes
- risk assessment
- high resolution
- atomic force microscopy
- radiation therapy
- free survival
- mass spectrometry
- single molecule